Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Spring Bank Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Spring Bank Pharmaceuticals (United States)

Hopkinton, Massachusettscompany

109

Works

4,308

Citations

33

h-index

Top Research Topics

interferon and immune responses Hepatitis B Virus Studies Environmental Toxicology and Ecotoxicology

Top Researchers

Nezam H. Afdhal Beth Israel Deaconess Medical Center

556 works34,698 citationsh-index: 92

Recent Research

Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United States

Chia Jie. Tan,Connor Willis,et al.

20260 citations

Neurofibromatosis and Schwannoma Cases

Cancer Research and Treatments

Hepatitis C virus research

Cancer Immunotherapy and Biomarkers

Sarcoma Diagnosis and Treatment

Pesticide and Herbicide Environmental Studies

Melanoma and MAPK Pathways

Water Quality and Pollution Assessment

Soft tissue tumor case studies

Mark P. Johnson Acharya N. G. Ranga Agricultural University

841 works31,730 citationsh-index: 81

John F. McCarthy University of Washington

507 works20,970 citationsh-index: 75

Steven H. Lin The University of Texas MD Anderson Cancer Center

774 works19,431 citationsh-index: 71

Robert Cohen Inserm

1,007 works18,936 citationsh-index: 67

J. Smith Oak Ridge National Laboratory

398 works18,618 citationsh-index: 72

288MO Update from the long-term follow-up (LTFU) phase of ReNeu: A pivotal phase IIb trial of mirdametinib in adults and children with neurofibromatosis type 1 (NF1)-associated symptomatic plexiform neurofibroma (PN)

A. Hirbe,Hans Shuhaiber,et al.

20260 citations

Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours

Rachel N. Grisham,Elizabeth Hopp,et al.

20260 citations

EPID-12. Real-World Use of Medications With Moderate-to-Strong Cytochrome P450 3A4 (CYP3A4) Induction/Inhibition or Potential to Increase the Risk for Bleeding in Children and Adults with Neurofibromatosis Type 1-Associated Plexiform Neurofibroma (NF1-PN): A United States (US) Claims Database Analysis

Shengfan Zhou,Eileen Farrelly,et al.

20250 citations

CTNI-55. EXPLORING THE RELATIONSHIP BETWEEN PATIENT BASELINE CHARACTERISTICS WITH RESPONSES TO MIRDAMETINIB IN THE RENEU TRIAL OF CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)-ASSOCIATED PLEXIFORM NEUROFIBROMA (PN)

Timothy R. Gershon,Angela C. Hirbe,et al.

20250 citations

CTP-08. Efficacy and tolerability of mirdametinib (PD-0325901) in children, adolescents, and young adults with recurrent/progressive low-grade glioma: update from the SJ901 (NCT04923126) phase 1/2 clinical trial

Anna Vinitsky,Asim K. Bag,et al.

20250 citations